HCV-话题@MedSci

#HCV#

247篇内容 | 3940人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1257603, encodeId=bc24125e60353, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=LANCET：Sofosbuvir联合利巴韦林可有效治疗 HCV、HIV 共感染患者, objectType=article, longId=47052, objectId=b0694e05245, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b0694e05245, replyNumber=0, likeNumber=59, createdTime=2015-02-14, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b0694e05245, moduleTitle=LANCET：Sofosbuvir联合利巴韦林可有效治疗 HCV、HIV 共感染患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b0694e05245)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257602, encodeId=64ff125e602d7, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=CPFI：HCV感染可促使颈动脉粥样硬化发生和发展, objectType=article, longId=46349, objectId=222e4634977, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=222e4634977, replyNumber=0, likeNumber=61, createdTime=2015-01-30, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=222e4634977, moduleTitle=CPFI：HCV感染可促使颈动脉粥样硬化发生和发展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=222e4634977)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257601, encodeId=1ea3125e601c5, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=汤森路透--《HCV全球市场分析》, objectType=article, longId=46005, objectId=94564600544, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=94564600544, replyNumber=0, likeNumber=70, createdTime=2015-01-24, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=94564600544, moduleTitle=汤森路透--《HCV全球市场分析》, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=94564600544)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257600, encodeId=19bf125e6008d, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=罗氏推出新一代病毒载量检测试剂盒cobas HIV-1和cobas HCV, objectType=article, longId=43837, objectId=e6624383eaf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e6624383eaf, replyNumber=0, likeNumber=52, createdTime=2014-12-12, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e6624383eaf, moduleTitle=罗氏推出新一代病毒载量检测试剂盒cobas HIV-1和cobas HCV, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e6624383eaf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257599, encodeId=8b68125e599b4, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=Nature：穷人难以用上全新的抗HCV药物, objectType=article, longId=40107, objectId=52cd4010e7e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=52cd4010e7e, replyNumber=0, likeNumber=64, createdTime=2014-09-11, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=52cd4010e7e, moduleTitle=Nature：穷人难以用上全新的抗HCV药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=52cd4010e7e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257598, encodeId=58ab125e5980a, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=STM：cART治疗HIV/HCV共感染患者有效, objectType=article, longId=38269, objectId=100d382693c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=100d382693c, replyNumber=0, likeNumber=95, createdTime=2014-07-27, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=100d382693c, moduleTitle=STM：cART治疗HIV/HCV共感染患者有效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=100d382693c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257597, encodeId=16f7125e5976b, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=J Virol：HCV致病性和感染性研究获进展, objectType=article, longId=35545, objectId=077735545fe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=077735545fe, replyNumber=0, likeNumber=78, createdTime=2014-05-30, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=077735545fe, moduleTitle=J Virol：HCV致病性和感染性研究获进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=077735545fe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257596, encodeId=59c6125e596b8, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=EASL 2014：DCV+SOF可有效治疗HCV基因1,2,3型感染者, objectType=article, longId=34696, objectId=45bb34696ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=45bb34696ff, replyNumber=0, likeNumber=60, createdTime=2014-05-15, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=45bb34696ff, moduleTitle=EASL 2014：DCV+SOF可有效治疗HCV基因1,2,3型感染者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=45bb34696ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257595, encodeId=c048125e595e0, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=EASL 2014：慢性HCV患者治疗决策相关的合并症, objectType=article, longId=34694, objectId=8f97346945f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8f97346945f, replyNumber=0, likeNumber=80, createdTime=2014-05-15, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8f97346945f, moduleTitle=EASL 2014：慢性HCV患者治疗决策相关的合并症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8f97346945f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257593, encodeId=b3e2125e59353, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=EASL 2014：3D+RBV治疗HCV1型感染非肝硬化者SVR率高, objectType=article, longId=34634, objectId=519534634ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=519534634ab, replyNumber=0, likeNumber=66, createdTime=2014-05-15, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=519534634ab, moduleTitle=EASL 2014：3D+RBV治疗HCV1型感染非肝硬化者SVR率高, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=519534634ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257594, encodeId=adef125e594e7, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=EASL 2014：MK-5172和MK-8742可有效治疗HCV1型和HIV共感染者, objectType=article, longId=34635, objectId=f0983463593, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f0983463593, replyNumber=0, likeNumber=76, createdTime=2014-05-15, rootId=0, userName=智智灵药, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f0983463593, moduleTitle=EASL 2014：MK-5172和MK-8742可有效治疗HCV1型和HIV共感染者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f0983463593)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257592, encodeId=4368125e592b7, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=Gastroenterology：改良的AFP模型可提高预测HCV肝硬化患者发生肝癌的能力, objectType=article, longId=34496, objectId=39fb3449634, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=39fb3449634, replyNumber=0, likeNumber=86, createdTime=2014-05-10, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=39fb3449634, moduleTitle=Gastroenterology：改良的AFP模型可提高预测HCV肝硬化患者发生肝癌的能力, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=39fb3449634)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257591, encodeId=a28e125e59173, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=EASL 2014：含SOF/LDV方案可有效治疗HCV基因1型初治患者, objectType=article, longId=33364, objectId=f59d333646f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f59d333646f, replyNumber=0, likeNumber=70, createdTime=2014-04-16, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f59d333646f, moduleTitle=EASL 2014：含SOF/LDV方案可有效治疗HCV基因1型初治患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f59d333646f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257590, encodeId=db2f125e59078, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=EASL 2014：MK-5172和MK-8742可有效治疗难治性1型HCV, objectType=article, longId=33363, objectId=f8e23336379, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f8e23336379, replyNumber=0, likeNumber=101, createdTime=2014-04-16, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f8e23336379, moduleTitle=EASL 2014：MK-5172和MK-8742可有效治疗难治性1型HCV, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f8e23336379)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257589, encodeId=413c125e589cf, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=EASL 2014：sofosbuvir+RBV对HCV肝硬化患者安全有效, objectType=article, longId=33342, objectId=12a933342f0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=12a933342f0, replyNumber=0, likeNumber=75, createdTime=2014-04-16, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=12a933342f0, moduleTitle=EASL 2014：sofosbuvir+RBV对HCV肝硬化患者安全有效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=12a933342f0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257588, encodeId=f724125e588b8, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=EASL 2014：Sofosbuvir可有效治疗肝移植术后HCV的复发, objectType=article, longId=33337, objectId=8a883333e23, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8a883333e23, replyNumber=0, likeNumber=61, createdTime=2014-04-16, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8a883333e23, moduleTitle=EASL 2014：Sofosbuvir可有效治疗肝移植术后HCV的复发, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8a883333e23)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257587, encodeId=e137125e58715, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=Hepatology：HIV/HCV共感染患者的肝纤维化进展迅速, objectType=article, longId=32811, objectId=8315328112d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8315328112d, replyNumber=0, likeNumber=67, createdTime=2014-04-04, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8315328112d, moduleTitle=Hepatology：HIV/HCV共感染患者的肝纤维化进展迅速, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8315328112d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257586, encodeId=afc6125e586bf, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=Hepatology：不同HCV感染者对治疗的敏感性差异的机制, objectType=article, longId=32735, objectId=62e532e3583, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=62e532e3583, replyNumber=0, likeNumber=83, createdTime=2014-04-03, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=62e532e3583, moduleTitle=Hepatology：不同HCV感染者对治疗的敏感性差异的机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=62e532e3583)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257584, encodeId=abd7125e584a9, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=勃林格faldaprevir治疗HCV/HIV合并感染III期取得积极数据, objectType=article, longId=31630, objectId=b140316307c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b140316307c, replyNumber=0, likeNumber=75, createdTime=2014-03-09, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b140316307c, moduleTitle=勃林格faldaprevir治疗HCV/HIV合并感染III期取得积极数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b140316307c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257585, encodeId=2d71125e58554, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=默沙东MK-5172/MK-8742治疗HIV/HCV感染疗效强劲, objectType=article, longId=31632, objectId=c71631632a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c71631632a3, replyNumber=0, likeNumber=70, createdTime=2014-03-09, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c71631632a3, moduleTitle=默沙东MK-5172/MK-8742治疗HIV/HCV感染疗效强劲, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c71631632a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

HCV

2020-05-29

ymljack (审核中...)

前往app查看评论内容

#HCV#

LANCET：Sofosbuvir联合利巴韦林可有效治疗 HCV、HIV 共感染患者

2015-02-14

ymljack (审核中...)

前往app查看评论内容

#HCV#

CPFI：HCV感染可促使颈动脉粥样硬化发生和发展

2015-01-30

ymljack (审核中...)

前往app查看评论内容

#HCV#

汤森路透--《HCV全球市场分析》

2015-01-24

ymljack (审核中...)

前往app查看评论内容

#HCV#

罗氏推出新一代病毒载量检测试剂盒cobas HIV-1和cobas HCV

2014-12-12

ymljack (审核中...)

前往app查看评论内容

#HCV#

Nature：穷人难以用上全新的抗HCV药物

2014-09-11

ymljack (审核中...)

前往app查看评论内容

#HCV#

STM：cART治疗HIV/HCV共感染患者有效

2014-07-27

ymljack (审核中...)

前往app查看评论内容

#HCV#

J Virol：HCV致病性和感染性研究获进展

2014-05-30

ymljack (审核中...)

前往app查看评论内容

#HCV#

EASL 2014：DCV+SOF可有效治疗HCV基因1,2,3型感染者

2014-05-15

ymljack (审核中...)

前往app查看评论内容

#HCV#

EASL 2014：慢性HCV患者治疗决策相关的合并症

2014-05-15

ymljack (审核中...)

前往app查看评论内容

#HCV#

EASL 2014：3D+RBV治疗HCV1型感染非肝硬化者SVR率高

2014-05-15

智智灵药 (审核中...)

前往app查看评论内容

#HCV#

EASL 2014：MK-5172和MK-8742可有效治疗HCV1型和HIV共感染者

2014-05-15

ymljack (审核中...)

前往app查看评论内容

#HCV#

Gastroenterology：改良的AFP模型可提高预测HCV肝硬化患者发生肝癌的能力

2014-05-10

ymljack (审核中...)

前往app查看评论内容

#HCV#

EASL 2014：含SOF/LDV方案可有效治疗HCV基因1型初治患者

2014-04-16

ymljack (审核中...)

前往app查看评论内容

#HCV#

EASL 2014：MK-5172和MK-8742可有效治疗难治性1型HCV

2014-04-16

ymljack (审核中...)

前往app查看评论内容

#HCV#

EASL 2014：sofosbuvir+RBV对HCV肝硬化患者安全有效

2014-04-16

ymljack (审核中...)

前往app查看评论内容

#HCV#

EASL 2014：Sofosbuvir可有效治疗肝移植术后HCV的复发

2014-04-16

ymljack (审核中...)

前往app查看评论内容

#HCV#

Hepatology：HIV/HCV共感染患者的肝纤维化进展迅速

2014-04-04

ymljack (审核中...)

前往app查看评论内容

#HCV#

Hepatology：不同HCV感染者对治疗的敏感性差异的机制

2014-04-03

ymljack (审核中...)

前往app查看评论内容

#HCV#

勃林格faldaprevir治疗HCV/HIV合并感染III期取得积极数据

2014-03-09

ymljack (审核中...)

前往app查看评论内容

#HCV#

默沙东MK-5172/MK-8742治疗HIV/HCV感染疗效强劲

2014-03-09

科室
- - 订阅+
  - 更多科室
工具
服务